Phillip Land
Medical · Lexington, NCNPI 1942378617
Payments from drug & device makers
Across 171 payments — averaging $14.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$362
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$207
- Biohaven Pharmaceutical Holding Company Ltd.$138
- Lilly USA, LLC$138
- Biohaven Pharmaceuticals, Inc.$135
- Sanofi-aventis U.S. LLC$128
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,43298%
- Education$602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $362 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $207 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $138 |
| Lilly USA, LLC | 9 | $138 |
| Biohaven Pharmaceuticals, Inc. | 10 | $135 |
| Sanofi-aventis U.S. LLC | 9 | $128 |
| Novo Nordisk | 8 | $111 |
| GSK | 7 | $107 |
| Pfizer | 7 | $107 |
| Otsuka America Pharmaceutical, Inc. | 6 | $98 |
| Forte Bio-pharma LLC | 2 | $93 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $89 |
| Boehringer Ingelheim | 5 | $75 |
| Novartis | 5 | $65 |
| Amarin Pharma, Inc. | 3 | $61 |
| Abbott | 1 | $53 |
| Amgen | 3 | $42 |
| Indivior Inc. | 3 | $40 |
| Alkermes, Inc. | 2 | $38 |
| Sunovion Pharmaceuticals Inc. | 4 | $35 |
| Scilex Pharmaceuticals Inc. | 1 | $34 |
| AstraZeneca | 2 | $30 |
| Mylan Specialty L.p. | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Eisai Inc. | 2 | $26 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Biogen | 2 | $25 |
| Boston Scientific | 1 | $22 |
| Virtus Pharmaceuticals LLC | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Corium, LLC | 1 | $13 |
| Merck | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,492 in reported general payments places this provider in the 75th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sertraline Hcl | 13 | $273 |
Paid to pharmacies, not to this prescriber.
Other medical in Lexington
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
- Ashley TipperStatesville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.